ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02413489
Brief Title: An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

First Submitted : April 7, 2015
First Submitted that Met QC Criteria : April 7, 2015
First Posted : April 10, 2015 (Estimate)

Results First Submitted : May 28, 2018
Results First Submitted that Met QC Criteria : May 28, 2018
Results First Posted : June 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : May 28, 2018
Last Update Posted : June 25, 2018 (Estimate)